IPO Details
Bidding Dates
29 Nov 24 - 03 Dec 24
Price Range ₹
420 - 441
Total Equity
₹ 592.37Cr
Lot Size
34
Exchange Status
NSE,BSE
IPO Doc
Subscription Rate
Non-Institutional Investor
0.95×
Qualified Institutional Buyers
1.74×
Employees
0.00×
Retail Investors
0.95×
Total subscription Rate
1.27×
IPO Timeline
Offer start
29 Nov 2024
Offer end
03 Dec 2024
Allotment
04 Dec 2024
Refund initiation
05 Dec 2024
Demat transfer
05 Dec 2024
Listing
06 Dec 2024
Offer start
29 Nov 2024
Offer end
03 Dec 2024
Allotment
04 Dec 2024
Refund initiation
05 Dec 2024
Demat transfer
05 Dec 2024
Listing
06 Dec 2024
About Company
Incorporated in 2005, Suraksha Diagnostic Limited specializes in pathology, radiology testing, and medical consultancy services. The company operates a central reference laboratory supported by 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centers and 166 sample collection centers, as of June 30, 2024. These facilities span across West Bengal, Bihar, Assam, and Meghalaya. Suraksha Diagnostic Limited provides both online and offline medical consultation services through 44 diagnostic centers, which also host 120 polyclinics with a network of over 750 doctors. The company’s diagnostic operations are powered by advanced technology systems, including a Laboratory Information Management System (LIMS), an integrated Radiology Information System (RIS), a Picture Archive Communication System (PACS), and an Enterprise Resource Planning System (ERP), ensuring seamless and efficient processes. Additionally, the company offers vaccination services and tailored testing packages for disease prediction and early detection. Leveraging digital pathology and artificial intelligence, it enhances the accuracy and efficiency of blood testing. Radiology reporting is managed entirely through a digital platform, enabling faster case processing and reducing turnaround times across all diagnostic centers.
Year Founded
15-03-2005
Promotor Details
Somnath Chatterjee
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 61.07 | 48.78 |
| Share Capital | 31802034 | 25405590 |
Offer to Public
1,34,32,533.00 Cr
Project Details
- None - Nonecr
Highlights
- Suraksha Diagnostic Limited holds a leading position in the diagnostic market of eastern India, with significant growth potential in a fragmented industry.
- The company provides a wide range of diagnostic services, including pathology, radiology, and medical consultations, catering to diverse healthcare needs under one roof.
- Equipped with cutting-edge technology, such as LIMS, RIS, PACS, and ERP systems, and supported by skilled professionals, the company ensures accurate and reliable diagnostic services.
- Suraksha Diagnostic is a trusted name in the healthcare industry, known for its commitment to quality and customer-centric services.
- The company prioritizes personalized care, offering vaccination services and customized testing packages for early disease detection and prevention, further enhancing customer loyalty.
Challenges
- The company heavily relies on West Bengal for its business, making it vulnerable to regional disruptions that could significantly impact overall performance.
- Staying updated with new diagnostic tests and technologies is critical, and any delays in adoption could weaken the company’s competitive position.
- The reliance on third-party vendors for testing equipment makes the company susceptible to supply chain disruptions, which could hinder operations.
- Many sample collection centers are franchise-operated, and failure to maintain consistent quality standards could harm the company’s reputation and service reliability.
- Intense competition in the diagnostics industry may lead to price reductions, potentially impacting profit margins and overall financial performance.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2020 | 1,72,87,48,300.00 | 8,52,85,900.00 | 60.65 | 65.16 | 94.4348 |
| 2022 | 20,071.72 | 852.86 | 60.65 | 65.16 | 94.4348 |
| 2024 | 3,002.07 | 85.29 | 2,374.96 | 2,374.96 | 344.1971 |
| 2021 | 17,104.73 | 852.86 | 643.51 | 643.51 | 93.2623 |
| 2023 | 2,811.95 | 85.29 | 643.51 | 643.51 | 93.2623 |
